Navigation Links
Eric J. Topol, M.D. presented with 2011 TCT Career Achievement Award

SAN FRANCISCO NOVEMBER 9, 2011 Eric J. Topol, MD, a world-renowned cardiologist and physician-scientist, was presented the 2011 TCT Career Achievement Award in a ceremony held today during the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). The award is given each year to a pioneer in the field of interventional cardiovascular medicine.

One of the leading cardiologists in the United States, Dr. Topol spearheaded the discovery of multiple genes which increase a person's risk of heart attacks and pioneered the development of critical heart care therapies now used in daily practice therapies such as clot busters, anti-platelet agents and angioplasty devices. He has led more than 15 international, multi-center research trials involving 40 countries and more than 200,000 patients. He is also a leader in the movement to modernize medical treatment through wireless digital innovative technologies.

TCT Directors, Martin B. Leon, MD and Gregg W. Stone, MD jointly presented the award, which recognizes pioneering work in interventional medicine and extraordinary talent and dedication in both research and clinical endeavors. Dr. Leon is the Founder of CRF and Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Stone is Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Both serve as Co-Directors of the Medical Research and Education Division at CRF.

"We are proud to honor Dr. Topol with the TCT 2011 Career Achievement Award," said Dr. Stone. "As a clinical trialist and educator, Dr. Topol has set the benchmark to which we all aspire. His ground-breaking research in acute myocardial infarction and interventional pharmacology has directly benefitted millions of patients with cardiovascular disease. And now, his singular devotion to cardiovascular genomics promises to open a window to novel approaches for the prevention and treatment of heart disease."

"Dr. Topol's current work in personalized medicine and digital technology positions him as a leader in the movement to modernize medical treatment - creating new, more effective ways to treat patients," Dr. Leon added. "His ground-breaking research in cardiology and genomics has provided more treatment and prevention options for patients and transformed our understanding of how genetics can determine a person's risk of heart disease."

Dr. Topol is currently a Professor of Genomics at The Scripps Research Institute and Chief Academic Officer of Scripps Health in La Jolla, California. He also leads the flagship NIH supported Scripps Translational Science Institute and is a co-Founder and the Vice-Chairman of the West Wireless Health Institute.

Previously, Dr. Topol served as Chair of the Department of Cardiovascular Medicine at the Cleveland Clinic, where his cardiovascular program was ranked by U.S. News & World Report as number one in the nation in patient care and research for 12 years. His upcoming book, The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care, which addresses the convergence of the digital revolution and medicine, will be released in January 2012.


Contact: Judy Romero
Cardiovascular Research Foundation

Related medicine news :

1. Connor Sport Court Lays the Ground for NBA All-Star Jam Session Presented by Adidas
2. Digital Signatures Presented at Electronic Document Management Conference
3. Compex , Leaders in Electronic Muscle Stimulators, Sponsors the Jelly Belly Cycling Team Presented by Kenda
4. Game Ready(R) Presented with Frost & Sullivan 2010 Product Differentiation Excellence Award
5. New Data from Caldolor(R) Study in Burn Patients to be Presented at 42nd Annual Meeting of The American Burn Association
6. Nine Healthcare Companies Named Finalists for Innovations in HealthcareSM ABBY Awards, to be Presented April 28th
7. Zimmer Receives Recognition for Health Economics Data Presented at 77th Annual American Academy of Orthopaedic Surgeons Meeting
8. BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR
9. The Arnold Palmer Invitational Presented by MasterCard Expands Relationship with MasterCard to Offer Exclusive Prepaid Business Gift Cards
10. Seat Belt Champion Award Presented to Florida Legislators
11. OTC Perspectives Announces 2010 Ad Awards Finalists Presented by HealthCentral
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology: